Publications – 2004

  • Tsao L, Gibson CM. Heart failure: an epidemic of the 21st century. Crit Pathw Cardiol. 2004 Dec;3(4):194-204. doi: 10.1097/01.hpc.0000146867.90558.ca.
  • Baggish AL, Cameron R, Anwaruddin S, Chen AA, Krauser DG, Tung R, Januzzi JL Jr. A clinical and biochemical critical pathway for the evaluation of patients with suspected acute congestive heart failure: The ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) algorithm. Crit Pathw Cardiol. 2004 Dec;3(4):171-6. doi: 10.1097/01.hpc.0000145817.68289.a2.
  • Herrmann HC, Murphy SA, Dibattiste PM, Delucca PT, Demopoulos LA, Gibson CM, Cannon CP. Greater benefit of early invasive strategy for unstable angina and non-ST elevation myocardial infarction in United States compared with non-United States patients: a TACTICS-TIMI 18 substudy. Crit Pathw Cardiol. 2004 Jun;3(2):95-100. doi: 10.1097/01.hpc.0000131548.11420.86.
  • Cannon CP. Risk stratification and the management of non-ST-segment elevation acute coronary syndromes: the role of antiplatelet therapy. Crit Pathw Cardiol. 2004 Jun;3(2):83-6. doi: 10.1097/01.hpc.0000128716.20083.4d.
  • Moyer P, Feldman J, Levine J, Beshansky J, Selker HP, Barnewolt B, Brown DF, Cardoza JP Jr, Grossman SA, Jacobs A, Kerman BJ, Kimmelstiel C, Larson R, Losordo D, Pearlmutter M, Pozner C, Ramirez A, Rosenfield K, Ryan TJ, Zane RD, Cannon CP. Implications of the mechanical (PCI) vs thrombolytic controversy for ST segment elevation myocardial infarction on the organization of emergency medical services: the Boston EMS experience. Crit Pathw Cardiol. 2004 Jun;3(2):53-61. doi: 10.1097/01.hpc.0000128714.35330.6d.
  • Cannon CP. Cost-effectiveness of clopidogrel. Pharmacoeconomics. 2004;22 Suppl 4:1-3. doi: 10.2165/00019053-200422004-00002.
  • Kuntz RE, Wang JC, Mauri L, Cohen DJ. An evidence-based approach to the use of drug-eluting stents in clinical practice. Am Heart Hosp J. 2004 Summer;2(3):132-41. doi: 10.1111/j.1541-9215.2004.02660.x.
  • Ray KK, Cannon CP. Pathological changes in acute coronary syndromes: the role of statin therapy in the modulation of inflammation, endothelial function and coagulation. J Thromb Thrombolysis. 2004 Oct;18(2):89-101. doi: 10.1007/s11239-004-0205-9.
  • Hobson RW 2nd, Howard VJ, Roubin GS, Brott TG, Ferguson RD, Popma JJ, Graham DL, Howard G; CREST Investigators. Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase. J Vasc Surg. 2004 Dec;40(6):1106-11. doi: 10.1016/j.jvs.2004.10.022.
  • Popma JJ, Leon MB, Moses JW, Holmes DR Jr, Cox N, Fitzpatrick M, Douglas J, Lambert C, Mooney M, Yakubov S, Kuntz RE; SIRIUS Investigators. Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries. Circulation. 2004 Dec 21;110(25):3773-80. doi: 10.1161/01.CIR.0000150331.14687.4B. Epub 2004 Dec 13.
  • Karha J, Gibson CM, Murphy SA, Dibattiste PM, Cannon CP; TIMI Study Group. Safety of stress testing during the evolution of unstable angina pectoris or non-ST-elevation myocardial infarction. Am J Cardiol. 2004 Dec 15;94(12):1537-9. doi: 10.1016/j.amjcard.2004.08.033.
  • Kaushal K, Bhattacharyya A, Gibson CM, Varghese B, Davis JR. Adequacy of information delivered to patients during consultation for thyrotoxicosis. Clin Endocrinol (Oxf). 2004 Dec;61(6):778-9. doi: 10.1111/j.1365-2265.2004.02141.x.
  • Turakhia MP, Murphy SA, Pinto TL, Antman EM, Giugliano RP, Cannon CP, Braunwald E, Gibson CM; Thrombolysis in Myocardial Infarction Study Group. Association of platelet count with residual thrombus in the myocardial infarct-related coronary artery among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction. Am J Cardiol. 2004 Dec 1;94(11):1406-10. doi: 10.1016/j.amjcard.2004.08.015.
  • Fox CS, Coady S, Sorlie PD, Levy D, Meigs JB, D’Agostino RB Sr, Wilson PW, Savage PJ. Trends in cardiovascular complications of diabetes. JAMA. 2004 Nov 24;292(20):2495-9. doi: 10.1001/jama.292.20.2495.
  • Wang TJ, Parise H, Levy D, D’Agostino RB Sr, Wolf PA, Vasan RS, Benjamin EJ. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004 Nov 24;292(20):2471-7. doi: 10.1001/jama.292.20.2471.
  • Reynolds MR, Joventino LP, Josephson ME; Miracle ICD Investigators. Relationship of baseline electrocardiographic characteristics with the response to cardiac resynchronization therapy for heart failure. Pacing Clin Electrophysiol. 2004 Nov;27(11):1513-8. doi: 10.1111/j.1540-8159.2004.00669.x.
  • Gibson CM, Dumaine RL, Gelfand EV, Murphy SA, Morrow DA, Wiviott SD, Giugliano RP, Cannon CP, Antman EM, Braunwald E; TIMI Study Group. Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials. Eur Heart J. 2004 Nov;25(22):1998-2005. doi: 10.1016/j.ehj.2004.08.016.
  • Seshadri S, Wolf PA, Beiser A, Elias MF, Au R, Kase CS, D’Agostino RB, DeCarli C. Stroke risk profile, brain volume, and cognitive function: the Framingham Offspring Study. Neurology. 2004 Nov 9;63(9):1591-9. doi: 10.1212/01.wnl.0000142968.22691.70.
  • Taylor AL, Ziesche S, Yancy C, Carson P, D’Agostino R Jr, Ferdinand K, Taylor M, Adams K, Sabolinski M, Worcel M, Cohn JN; African-American Heart Failure Trial Investigators. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med. 2004 Nov 11;351(20):2049-57. doi: 10.1056/NEJMoa042934. Epub 2004 Nov 8.
  • Tarantino V, D’Agostino R, Melagrana A, Porcu A, Stura M, Vallarino R, Calevo MG. Safety of electronic molecular resonance adenoidectomy. Int J Pediatr Otorhinolaryngol. 2004 Dec;68(12):1519-23. doi: 10.1016/j.ijporl.2004.07.013.
  • Ray KK, Cannon CP. Intensive statin therapy in acute coronary syndromes: clinical benefits and vascular biology. Curr Opin Lipidol. 2004 Dec;15(6):637-43. doi: 10.1097/00041433-200412000-00003.
  • Faintuch S, Lang EV, Cohen RI, Pinto DS. Inhaled nitric oxide as an adjunct to suction thrombectomy for pulmonary embolism. J Vasc Interv Radiol. 2004 Nov;15(11):1311-5. doi: 10.1097/01.RVI.0000137979.63175.B6.
  • Bhatt DL, Roe MT, Peterson ED, Li Y, Chen AY, Harrington RA, Greenbaum AB, Berger PB, Cannon CP, Cohen DJ, Gibson CM, Saucedo JF, Kleiman NS, Hochman JS, Boden WE, Brindis RG, Peacock WF, Smith SC Jr, Pollack CV Jr, Gibler WB, Ohman EM; CRUSADE Investigators. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA. 2004 Nov 3;292(17):2096-104. doi: 10.1001/jama.292.17.2096.
  • Cohen DJ, Murphy SA, Baim DS, Lavelle TA, Berezin RH, Cutlip DE, Ho KK, Kuntz RE; SAFER Trial Investigators. Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trial. J Am Coll Cardiol. 2004 Nov 2;44(9):1801-8. doi: 10.1016/j.jacc.2004.05.086.
  • Cox N, Resnic FS, Popma JJ, Simon DI, Eisenhauer AC, Rogers C. Comparison of the risk of vascular complications associated with femoral and radial access coronary catheterization procedures in obese versus nonobese patients. Am J Cardiol. 2004 Nov 1;94(9):1174-7. doi: 10.1016/j.amjcard.2004.07.088.
  • Karmpaliotis D, Turakhia MP, Kirtane AJ, Murphy SA, Kosmidou I, Morrow DA, Giugliano RP, Cannon CP, Antman EM, Braunwald E, Gibson CM; TIMI Study Group. Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction. Am J Cardiol. 2004 Nov 1;94(9):1113-7. doi: 10.1016/j.amjcard.2004.07.075.
  • Gibson CM. NRMI and current treatment patterns for ST-elevation myocardial infarction. Am Heart J. 2004 Nov;148(5 Suppl):S29-33. doi: 10.1016/j.ahj.2004.09.012.
  • Lemos PA, Mercado N, van Domburg RT, Kuntz RE, O’Neill WW, Serruys PW. Comparison of late luminal loss response pattern after sirolimus-eluting stent implantation or conventional stenting. Circulation. 2004 Nov 16;110(20):3199-205. doi: 10.1161/01.CIR.0000147275.50550.68. Epub 2004 Oct 25.
  • Baim DS. New devices for percutaneous coronary intervention are rapidly making bypass surgery obsolete. Curr Opin Cardiol. 2004 Nov;19(6):593-7. doi: 10.1097/01.hco.0000142065.37837.b4.
  • Januzzi JL Jr. Ask the doctor. Every day I take a baby aspirin (81 milligrams) that is coated to protect my stomach. Out of curiosity, I dropped a tablet into a glass filled with equal parts water and vinegar. Two days later, it hadn’t dissolved. That has me wondering if the aspirin inside the coating gets into my stomach and bloodstream, or whether I’ve been unprotected against heart disease all this time?. Harv Heart Lett. 2004 Oct;15(2):8.
  • Sattar N, Williams K, Sniderman AD, D’Agostino R Jr, Haffner SM. Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study. Circulation. 2004 Oct 26;110(17):2687-93. doi: 10.1161/01.CIR.0000145660.60487.94. Epub 2004 Oct 18.
  • Dhingra R, Pencina MJ, Benjamin EJ, Levy D, Larson MG, Meigs JB, Rifai N, D’Agostino RB Sr, Vasan RS. Cross-sectional relations of urinary sodium excretion to cardiac structure and hypertrophy. The Framingham Heart Study. Am J Hypertens. 2004 Oct;17(10):891-6. doi: 10.1016/j.amjhyper.2004.06.008.
  • Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK, Whitlow P, Strickman NE, Jaff MR, Popma JJ, Snead DB, Cutlip DE, Firth BG, Ouriel K; Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy Investigators. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004 Oct 7;351(15):1493-501. doi: 10.1056/NEJMoa040127.
  • Loffredo JT, Sidney J, Wojewoda C, Dodds E, Reynolds MR, Napoé G, Mothé BR, O’Connor DH, Wilson NA, Watkins DI, Sette A. Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition. J Immunol. 2004 Oct 15;173(8):5064-76. doi: 10.4049/jimmunol.173.8.5064.
  • Sam C, Massaro JM, D’Agostino RB Sr, Levy D, Lambert JW, Wolf PA, Benjamin EJ; Framingham Heart Study. Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (the Framingham Heart Study). Am J Cardiol. 2004 Oct 1;94(7):947-51. doi: 10.1016/j.amjcard.2004.06.038.
  • Kathiresan S, Servoss SJ, Newell JB, Trani D, MacGillivray TE, Lewandrowski K, Lee-Lewandrowski E, Januzzi JL Jr. Cardiac troponin T elevation after coronary artery bypass grafting is associated with increased one-year mortality. Am J Cardiol. 2004 Oct 1;94(7):879-81. doi: 10.1016/j.amjcard.2004.06.022.
  • Baim DS, Braden G, Heuser R, Popma JJ, Cutlip DE, Massaro JM, Marulkar S, Arvay LJ, Kuntz RE; Guided Radio Frequency Energy Ablation of Total Occlusions Registry Study. Utility of the Safe-Cross-guided radiofrequency total occlusion crossing system in chronic coronary total occlusions (results from the Guided Radio Frequency Energy Ablation of Total Occlusions Registry Study). Am J Cardiol. 2004 Oct 1;94(7):853-8. doi: 10.1016/j.amjcard.2004.06.017.
  • Kashani A, Giugliano RP, Antman EM, Morrow DA, Gibson CM, Murphy SA, Braunwald E. Severity of heart failure, treatments, and outcomes after fibrinolysis in patients with ST-elevation myocardial infarction. Eur Heart J. 2004 Oct;25(19):1702-10. doi: 10.1016/j.ehj.2004.05.009.
  • Suh SO, Gibson CM, Blackwell M. Metschnikowia chrysoperlae sp. nov., Candida picachoensis sp. nov. and Candida pimensis sp. nov., isolated from the green lacewings Chrysoperla comanche and Chrysoperla carnea (Neuroptera: Chrysopidae). Int J Syst Evol Microbiol. 2004 Sep;54(Pt 5):1883-1890. doi: 10.1099/ijs.0.63152-0.
  • Bankier B, Januzzi JL, Littman AB. The high prevalence of multiple psychiatric disorders in stable outpatients with coronary heart disease. Psychosom Med. 2004 Sep-Oct;66(5):645-50. doi: 10.1097/01.psy.0000138126.90551.62.
  • Popma JJ, Berger P, Ohman EM, Harrington RA, Grines C, Weitz JI. Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004 Sep;126(3 Suppl):576S-599S. doi: 10.1378/chest.126.3_suppl.576S.
  • Menon V, Harrington RA, Hochman JS, Cannon CP, Goodman SD, Wilcox RG, Schünemann HJ, Ohman EM. Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004 Sep;126(3 Suppl):549S-575S. doi: 10.1378/chest.126.3_suppl.549S.
  • Morrow DA, Sabatine MS, Antman EM, Cannon CP, Braunwald E, Theroux P. Usefulness of tirofiban among patients treated without percutaneous coronary intervention (TIMI high risk patients in PRISM-PLUS). Am J Cardiol. 2004 Sep 15;94(6):774-6. doi: 10.1016/j.amjcard.2004.05.065.
  • Au R, Seshadri S, Wolf PA, Elias M, Elias P, Sullivan L, Beiser A, D’Agostino RB. New norms for a new generation: cognitive performance in the framingham offspring cohort. Exp Aging Res. 2004 Oct-Dec;30(4):333-58. doi: 10.1080/03610730490484380.
  • Djoussé L, Schatzkin A, Chibnik LB, D’Agostino RB, Kreger BE, Ellison RC. Alcohol consumption and the risk of bladder cancer in the Framingham Heart Study. J Natl Cancer Inst. 2004 Sep 15;96(18):1397-400. doi: 10.1093/jnci/djh263.
  • Jeremias A, Baim DS, Ho KK, Chauhan M, Carrozza JP Jr, Cohen DJ, Popma JJ, Kuntz RE, Cutlip DE. Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures. J Am Coll Cardiol. 2004 Sep 15;44(6):1210-4. doi: 10.1016/j.jacc.2004.06.051.
  • Ponec D, Jaff MR, Swischuk J, Feiring A, Laird J, Mehra M, Popma JJ, Donohoe D, Firth B, Keim E, Snead D; CRISP Study Investigators. The Nitinol SMART stent vs Wallstent for suboptimal iliac artery angioplasty: CRISP-US trial results. J Vasc Interv Radiol. 2004 Sep;15(9):911-8. doi: 10.1097/01.RVI.0000140935.45313.35.
  • Sadanandan S, Cannon CP, Chekuri K, Murphy SA, Dibattiste PM, Morrow DA, de Lemos JA, Braunwald E, Gibson CM. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2004 Aug 4;44(3):564-8. doi: 10.1016/j.jacc.2004.03.072.
  • Horowitz PM, Patterson KR, Guillozet-Bongaarts AL, Reynolds MR, Carroll CA, Weintraub ST, Bennett DA, Cryns VL, Berry RW, Binder LI. Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer’s disease. J Neurosci. 2004 Sep 8;24(36):7895-902. doi: 10.1523/JNEUROSCI.1988-04.2004.
  • Kirtane AJ, Bui A, Murphy SA, Karmpaliotis D, Kosmidou I, Boundy K, Rahman A, Pinto DS, Aroesty JM, Giugliano RP, Cannon CP, Antman EM, Gibson CM; TIMI Study Group. Association of epicardial and tissue-level reperfusion with left ventricular end-diastolic pressures in ST-elevation myocardial infarction. J Thromb Thrombolysis. 2004 Jun;17(3):177-84. doi: 10.1023/B:THRO.0000040486.10549.f6.
  • Baggish AL, MacGillivray TE, Hoffman W, Newell JB, Lewandrowski KB, Lee-Lewandrowski E, Anwaruddin S, Siebert U, Januzzi JL. Postoperative troponin-T predicts prolonged intensive care unit length of stay following cardiac surgery. Crit Care Med. 2004 Sep;32(9):1866-71. doi: 10.1097/01.ccm.0000139692.19371.7c.
  • Cannon CP. Revascularisation for everyone?. Eur Heart J. 2004 Sep;25(17):1471-2. doi: 10.1016/j.ehj.2004.05.019.
  • Krob HA, Fleischer AB Jr, D’Agostino R Jr, Haverstock CL, Feldman S. Prevalence and relevance of contact dermatitis allergens: a meta-analysis of 15 years of published T.R.U.E. test data. J Am Acad Dermatol. 2004 Sep;51(3):349-53. doi: 10.1016/j.jaad.2003.11.069.
  • Cutlip DE, Chhabra AG, Baim DS, Chauhan MS, Marulkar S, Massaro J, Bakhai A, Cohen DJ, Kuntz RE, Ho KK. Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials. Circulation. 2004 Sep 7;110(10):1226-30. doi: 10.1161/01.CIR.0000140721.27004.4B. Epub 2004 Aug 30.
  • Gibson CM, Murphy SA, Kirtane AJ, Giugliano RP, Cannon CP, Antman EM, Braunwald E; TIMI Study Group. Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2004 Sep 1;44(5):980-7. doi: 10.1016/j.jacc.2004.05.059.
  • Friedrich TC, McDermott AB, Reynolds MR, Piaskowski S, Fuenger S, De Souza IP, Rudersdorf R, Cullen C, Yant LJ, Vojnov L, Stephany J, Martin S, O’Connor DH, Wilson N, Watkins DI. Consequences of cytotoxic T-lymphocyte escape: common escape mutations in simian immunodeficiency virus are poorly recognized in naive hosts. J Virol. 2004 Sep;78(18):10064-73. doi: 10.1128/JVI.78.18.10064-10073.2004.
  • Gibson CM, Singh KP, Murphy SA, DiBattiste PM, Demopoulos LA, Cannon CP, Braunwald E; TIMI Study Group. Association between duration of tirofiban therapy before percutaneous intervention and tissue level perfusion (a TACTICS-TIMI 18 substudy). Am J Cardiol. 2004 Aug 15;94(4):492-4. doi: 10.1016/j.amjcard.2004.04.066.
  • Kruse RL, Mehr DR, Boles KE, Lave JR, Binder EF, Madsen R, D’Agostino RB. Does hospitalization impact survival after lower respiratory infection in nursing home residents?. Med Care. 2004 Sep;42(9):860-70. doi: 10.1097/01.mlr.0000135828.95415.b1.
  • Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, D’Agostino RB, Massaro JM, Beiser A, Wolf PA, Benjamin EJ. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004 Aug 31;110(9):1042-6. doi: 10.1161/01.CIR.0000140263.20897.42. Epub 2004 Aug 16.
  • Sadanandan S, Cannon CP, Gibson CM, Murphy SA, DiBattiste PM, Braunwald E; TIMI Study Group. A risk score to estimate the likelihood of coronary artery bypass surgery during the index hospitalization among patients with unstable angina and non-ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2004 Aug 18;44(4):799-803. doi: 10.1016/j.jacc.2004.03.081.
  • Wiviott SD, Morrow DA, Frederick PD, Giugliano RP, Gibson CM, McCabe CH, Cannon CP, Antman EM, Braunwald E. Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4: a simple index that predicts mortality in ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2004 Aug 18;44(4):783-9. doi: 10.1016/j.jacc.2004.05.045.
  • Gibson CM, Murphy SA, Morrow DA, Aroesty JM, Gibbons RJ, Gourlay SG, Barron HV, Giugliano RP, Antman EM, Braunwald E. Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction. Am Heart J. 2004 Aug;148(2):336-40. doi: 10.1016/j.ahj.2003.12.044.
  • Col NF, Weber G, Stiggelbout A, Chuo J, D’Agostino R, Corso P. Short-term menopausal hormone therapy for symptom relief: an updated decision model. Arch Intern Med. 2004 Aug 9-23;164(15):1634-40. doi: 10.1001/archinte.164.15.1634.
  • Patel GM, Hauser TH, Parker JA, Pinto DS, Sanders GP, Aepfelbacher FC, Koutkia P, Danias PG. Quantitative relationship of stress Tc-99m sestamibi lung uptake with resting Tl-201 lung uptake and with indices of left ventricular dysfunction and coronary artery disease. J Nucl Cardiol. 2004 Jul-Aug;11(4):408-13. doi: 10.1016/j.nuclcard.2004.03.032.
  • Zimetbaum PJ, Buxton AE, Batsford W, Fisher JD, Hafley GE, Lee KL, O’Toole MF, Page RL, Reynolds M, Josephson ME. Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial. Circulation. 2004 Aug 17;110(7):766-9. doi: 10.1161/01.CIR.0000139311.32278.32. Epub 2004 Aug 2.
  • Bach RG, Cannon CP, Weintraub WS, DiBattiste PM, Demopoulos LA, Anderson HV, DeLucca PT, Mahoney EM, Murphy SA, Braunwald E. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med. 2004 Aug 3;141(3):186-95. doi: 10.7326/0003-4819-141-3-200408030-00007.
  • Tung RH, Garcia C, Morss AM, Pino RM, Fifer MA, Thompson BT, Lewandrowski K, Lee-Lewandrowski E, Januzzi JL. Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock. Crit Care Med. 2004 Aug;32(8):1643-7. doi: 10.1097/01.ccm.0000133694.28370.7f.
  • D’Agostino RB Sr, Massaro JM. New developments in medical clinical trials. J Dent Res. 2004;83 Spec No C:C18-24. doi: 10.1177/154405910408301s04.
  • Cannon CP. Utilization of guidelines and computer-based technology to achieve optimal care in atherothrombotic vascular disease. J Thromb Thrombolysis. 2004 Feb;17(1):45-9. doi: 10.1023/B:THRO.0000036028.40658.62.
  • Januzzi JL, Marayati F, Mehta RH, Cooper JV, O’Gara PT, Sechtem U, Bossone E, Evangelista A, Oh JK, Nienaber CA, Eagle KA, Isselbacher EM. Comparison of aortic dissection in patients with and without Marfan’s syndrome (results from the International Registry of Aortic Dissection). Am J Cardiol. 2004 Aug 1;94(3):400-2. doi: 10.1016/j.amjcard.2004.04.049.
  • Kannel WB, Wilson PW, Nam BH, D’Agostino RB, Li J. A likely explanation for the J-curve of blood pressure cardiovascular risk. Am J Cardiol. 2004 Aug 1;94(3):380-4. doi: 10.1016/j.amjcard.2004.04.043.
  • Bolad I, MacLellan C, Karanam S, Parrella F, Michaud G, D’Agostino R, Shahian D, John R, Martin D. Effectiveness of early implantation of cardioverter defibrillator for postoperative ventricular tachyarrhythmia. Am J Cardiol. 2004 Aug 1;94(3):376-8. doi: 10.1016/j.amjcard.2004.04.041.
  • Cohen DJ, Bakhai A, Shi C, Githiora L, Lavelle T, Berezin RH, Leon MB, Moses JW, Carrozza JP Jr, Zidar JP, Kuntz RE; SIRIUS Investigators. Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial. Circulation. 2004 Aug 3;110(5):508-14. doi: 10.1161/01.CIR.0000136821.99814.43. Epub 2004 Jul 19.
  • Gibson CM, Jennings LK, Murphy SA, Lorenz DP, Giugliano RP, Harrington RA, Cholera S, Krishnan R, Califf RM, Braunwald E; INTEGRITI Study Group. Association between platelet receptor occupancy after eptifibatide (integrilin) therapy and patency, myocardial perfusion, and ST-segment resolution among patients with ST-segment-elevation myocardial infarction: an INTEGRITI (Integrilin and Tenecteplase in Acute Myocardial Infarction) substudy. Circulation. 2004 Aug 10;110(6):679-84. doi: 10.1161/01.CIR.0000137912.11655.F6. Epub 2004 Jul 19.
  • Rutter MK, Meigs JB, Sullivan LM, D’Agostino RB Sr, Wilson PW. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation. 2004 Jul 27;110(4):380-5. doi: 10.1161/01.CIR.0000136581.59584.0E. Epub 2004 Jul 19.
  • Mega JL, Morrow DA, De Lemos JA, Sabatine MS, Murphy SA, Rifai N, Gibson CM, Antman EM, Braunwald E. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy. J Am Coll Cardiol. 2004 Jul 21;44(2):335-9. doi: 10.1016/j.jacc.2004.04.033.
  • Wang JC, Normand SL, Mauri L, Kuntz RE. Coronary artery spatial distribution of acute myocardial infarction occlusions. Circulation. 2004 Jul 20;110(3):278-84. doi: 10.1161/01.CIR.0000135468.67850.F4. Epub 2004 Jul 12.
  • Sawhney N, Moses JW, Leon MB, Kuntz RE, Popma JJ, Bachinsky W, Bass T, DeMaio S, Fry E, Holmes DR Jr, Teirstein PS. Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents. Circulation. 2004 Jul 27;110(4):374-9. doi: 10.1161/01.CIR.0000136580.34604.B8. Epub 2004 Jul 12.
  • Hoffmann R, Langenberg R, Radke P, Franke A, Blindt R, Ortlepp J, Popma JJ, Weber C, Hanrath P. Evaluation of a high-dose dexamethasone-eluting stent. Am J Cardiol. 2004 Jul 15;94(2):193-5. doi: 10.1016/j.amjcard.2004.03.061.
  • Gardner GS, Frisch DR, Murphy SA, Kirtane AJ, Giugliano RP, Antman EM, Braunwald E, Gibson CM; TIMI Study Group. Effect of rescue or adjunctive percutaneous coronary intervention of the culprit artery after fibrinolytic administration on epicardial flow in nonculprit arteries. Am J Cardiol. 2004 Jul 15;94(2):178-81. doi: 10.1016/j.amjcard.2004.03.057.
  • Morrow DA, Antman EM, Murphy SA, Assmann SF, Giugliano RP, Cannon CP, Michael Gibson C, McCabe CH, Barron HV, Van De Werf F, Braunwald E. The Risk Score Profile: a novel approach to characterising the risk of populations enrolled in clinical studies. Eur Heart J. 2004 Jul;25(13):1139-45. doi: 10.1016/j.ehj.2004.04.036.
  • Springer SA, Pesanti E, Hodges J, Macura T, Doros G, Altice FL. Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community. Clin Infect Dis. 2004 Jun 15;38(12):1754-60. doi: 10.1086/421392. Epub 2004 May 26.
  • Januzzi JL, Maisel AS. Routine measurement of natriuretic peptide to guide the diagnosis and management of chronic heart failure. Circulation. 2004 Jun 29;109(25):e325-6; author reply e325-6. doi: 10.1161/01.CIR.0000132585.12965.D6.
  • Gibson CM, Schömig A. Coronary and myocardial angiography: angiographic assessment of both epicardial and myocardial perfusion. Circulation. 2004 Jun 29;109(25):3096-105. doi: 10.1161/01.CIR.0000134278.50359.CB.
  • Mehran R, Leon MB, Feigal DA, Jefferys D, Simons M, Chronos N, Fogarty TJ, Kuntz RE, Baim DS, Kaplan AV. Post-market approval surveillance: a call for a more integrated and comprehensive approach. Circulation. 2004 Jun 29;109(25):3073-7. doi: 10.1161/01.CIR.0000134694.78653.B6.
  • Kaplan AV, Baim DS, Smith JJ, Feigal DA, Simons M, Jefferys D, Fogarty TJ, Kuntz RE, Leon MB. Medical device development: from prototype to regulatory approval. Circulation. 2004 Jun 29;109(25):3068-72. doi: 10.1161/01.CIR.0000134695.65733.64.
  • Gibson CM, Bigelow B, James D, Tepper MR, Murphy SA, Kirtane AJ, Giugliano RP, Cannon CP, Antman EM; TIMI Study Group. Association of lesion complexity following fibrinolytic administration with mortality in ST-elevation myocardial infarction. Am J Cardiol. 2004 Jul 1;94(1):108-11. doi: 10.1016/j.amjcard.2004.03.038.
  • Lloyd-Jones DM, Wilson PW, Larson MG, Beiser A, Leip EP, D’Agostino RB, Levy D. Framingham risk score and prediction of lifetime risk for coronary heart disease. Am J Cardiol. 2004 Jul 1;94(1):20-4. doi: 10.1016/j.amjcard.2004.03.023.
  • Jeerakathil T, Wolf PA, Beiser A, Massaro J, Seshadri S, D’Agostino RB, DeCarli C. Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke. 2004 Aug;35(8):1857-61. doi: 10.1161/01.STR.0000135226.53499.85. Epub 2004 Jun 24.
  • Wylie JV, Murphy SA, Morrow DA, de Lemos JA, Antman EM, Cannon CP. Validated risk score predicts the development of congestive heart failure after presentation with unstable angina or non-ST-elevation myocardial infarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18. Am Heart J. 2004 Jul;148(1):173-80. doi: 10.1016/j.ahj.2003.12.018.
  • Kannel WB, D’Agostino RB, Sullivan L, Wilson PW. Concept and usefulness of cardiovascular risk profiles. Am Heart J. 2004 Jul;148(1):16-26. doi: 10.1016/j.ahj.2003.10.022.
  • Pencina MJ, D’Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med. 2004 Jul 15;23(13):2109-23. doi: 10.1002/sim.1802.
  • Fox CS, Parise H, D’Agostino RB Sr, Lloyd-Jones DM, Vasan RS, Wang TJ, Levy D, Wolf PA, Benjamin EJ. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA. 2004 Jun 16;291(23):2851-5. doi: 10.1001/jama.291.23.2851.
  • Melanson SF, Lewandrowski EL, Januzzi JL, Lewandrowski KB. Reevaluation of myoglobin for acute chest pain evaluation: would false-positive results on “first-draw” specimens lead to increased hospital admissions?. Am J Clin Pathol. 2004 Jun;121(6):804-8. doi: 10.1309/80MC-YMBL-4DLN-JDC3.
  • Nienaber CA, Fattori R, Mehta RH, Richartz BM, Evangelista A, Petzsch M, Cooper JV, Januzzi JL, Ince H, Sechtem U, Bossone E, Fang J, Smith DE, Isselbacher EM, Pape LA, Eagle KA; International Registry of Acute Aortic Dissection. Gender-related differences in acute aortic dissection. Circulation. 2004 Jun 22;109(24):3014-21. doi: 10.1161/01.CIR.0000130644.78677.2C. Epub 2004 Jun 14.
  • Gibson CM, de Lemos JA, Antman EM; TIMI Study Group. Time is muscle in primary PCI: the strength of the evidence grows. Eur Heart J. 2004 Jun;25(12):1001-2. doi: 10.1016/j.ehj.2004.04.029.
  • Haider AW, Roubenoff R, Wilson PW, Levy D, D’Agostino R, Silbershatz H, O’Donnell CJ. Monocyte cytokine production, systemic inflammation and cardiovascular disease in very elderly men and women: the Framingham Heart Study. Eur J Cardiovasc Prev Rehabil. 2004 Jun;11(3):214-5. doi: 10.1097/01.hjr.0000124212.21584.3c.
  • Liu J, Hong Y, D’Agostino RB Sr, Wu Z, Wang W, Sun J, Wilson PW, Kannel WB, Zhao D. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA. 2004 Jun 2;291(21):2591-9. doi: 10.1001/jama.291.21.2591.
  • Lader EW, Cannon CP, Ohman EM, Newby LK, Sulmasy DP, Barst RJ, Fair JM, Flather M, Freedman JE, Frye RL, Hand MM, Jesse RL, Van de Werf F, Costa F; American Heart Association. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis. Circulation. 2004 Jun 1;109(21):e305-7. doi: 10.1161/01.CIR.0000129020.43304.A7.
  • Lader EW, Cannon CP, Ohman EM, Newby LK, Sulmasy DP, Barst RJ, Fair JM, Flather M, Freedman JE, Frye RL, Hand MM, Jesse RL, Van de Werf F, Costa F; American Heart Association. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design. Circulation. 2004 Jun 1;109(21):e302-4. doi: 10.1161/01.CIR.0000128807.57602.61.
  • Lader EW, Cannon CP, Ohman EM, Newby LK, Sulmasy DP, Barst RJ, Fair JM, Flather M, Freedman JE, Frye RL, Hand MM, Jesse RL, Van de Werf F, Costa F; American College of Cardiology Foundation. The clinician as investigator: participating in clinical trials in the practice setting. Circulation. 2004 Jun 1;109(21):2672-9. doi: 10.1161/01.CIR.0000128702.16441.75.
  • Singh M, Gersh BJ, McClelland RL, Ho KK, Willerson JT, Penny WF, Holmes DR Jr. Clinical and angiographic predictors of restenosis after percutaneous coronary intervention: insights from the Prevention of Restenosis With Tranilast and Its Outcomes (PRESTO) trial. Circulation. 2004 Jun 8;109(22):2727-31. doi: 10.1161/01.CIR.0000131898.18849.65. Epub 2004 Jun 1.
  • Sonoda S, Morino Y, Ako J, Terashima M, Hassan AH, Bonneau HN, Leon MB, Moses JW, Yock PG, Honda Y, Kuntz RE, Fitzgerald PJ; SIRIUS Investigators. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial. J Am Coll Cardiol. 2004 Jun 2;43(11):1959-63. doi: 10.1016/j.jacc.2004.01.044.
  • Byrne CE, Fitzgerald A, Cannon CP, Fitzgerald DJ, Shields DC. Elevated white cell count in acute coronary syndromes: relationship to variants in inflammatory and thrombotic genes. BMC Med Genet. 2004 Jun 1;5:13. doi: 10.1186/1471-2350-5-13.
  • Giugliano RP, Sabatine MS, Gibson CM, Roe MT, Harrington RA, Murphy SA, Morrow DA, Antman EM, Braunwald E. Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion. Am J Cardiol. 2004 Jun 1;93(11):1362-7, A5-6. doi: 10.1016/j.amjcard.2004.02.031.
  • Mauri L, O’Malley AJ, Cutlip DE, Ho KK, Popma JJ, Chauhan MS, Baim DS, Cohen DJ, Kuntz RE. Effects of stent length and lesion length on coronary restenosis. Am J Cardiol. 2004 Jun 1;93(11):1340-6, A5. doi: 10.1016/j.amjcard.2004.02.027.
  • Festa A, D’Agostino R Jr, Hanley AJ, Karter AJ, Saad MF, Haffner SM. Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes. 2004 Jun;53(6):1549-55. doi: 10.2337/diabetes.53.6.1549.
  • Atwood LD, Wolf PA, Heard-Costa NL, Massaro JM, Beiser A, D’Agostino RB, DeCarli C. Genetic variation in white matter hyperintensity volume in the Framingham Study. Stroke. 2004 Jul;35(7):1609-13. doi: 10.1161/01.STR.0000129643.77045.10. Epub 2004 May 13.
  • Lloyd-Jones DM, Nam BH, D’Agostino RB Sr, Levy D, Murabito JM, Wang TJ, Wilson PW, O’Donnell CJ. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA. 2004 May 12;291(18):2204-11. doi: 10.1001/jama.291.18.2204.
  • Gibson CM, Karha J, Giugliano RP, Roe MT, Murphy SA, Harrington RA, Green CL, Schweiger MJ, Miklin JS, Baran KW, Palmeri S, Braunwald E, Krucoff MW; INTEGRITI Study Group. Association of the timing of ST-segment resolution with TIMI myocardial perfusion grade in acute myocardial infarction. Am Heart J. 2004 May;147(5):847-52. doi: 10.1016/j.ahj.2003.11.015.
  • Eaker ED, Sullivan LM, Kelly-Hayes M, D’Agostino RB Sr, Benjamin EJ. Does job strain increase the risk for coronary heart disease or death in men and women? The Framingham Offspring Study. Am J Epidemiol. 2004 May 15;159(10):950-8. doi: 10.1093/aje/kwh127.
  • Moussa I, Leon MB, Baim DS, O’Neill WW, Popma JJ, Buchbinder M, Midwall J, Simonton CA, Keim E, Wang P, Kuntz RE, Moses JW. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation. 2004 May 18;109(19):2273-8. doi: 10.1161/01.CIR.0000129767.45513.71. Epub 2004 May 3.
  • Sullivan LM, Massaro JM, D’Agostino RB Sr. Presentation of multivariate data for clinical use: The Framingham Study risk score functions. Stat Med. 2004 May 30;23(10):1631-60. doi: 10.1002/sim.1742.
  • D’Agostino RB Sr. The statistician and the data monitoring committee. Stat Med. 2004 May 30;23(10):1501-2. doi: 10.1002/sim.1873.
  • Fox CS, Heard-Costa NL, Wilson PW, Levy D, D’Agostino RB Sr, Atwood LD. Genome-wide linkage to chromosome 6 for waist circumference in the Framingham Heart Study. Diabetes. 2004 May;53(5):1399-402. doi: 10.2337/diabetes.53.5.1399.
  • Mehta RH, Bossone E, Evangelista A, O’Gara PT, Smith DE, Cooper JV, Oh JK, Januzzi JL, Hutchison S, Gilon D, Pape LA, Nienaber CA, Isselbacher EM, Eagle KA; International Registry of Acute Aortic Dissection Investigators. Acute type B aortic dissection in elderly patients: clinical features, outcomes, and simple risk stratification rule. Ann Thorac Surg. 2004 May;77(5):1622-8; discussion 1629. doi: 10.1016/j.athoracsur.2003.10.072.
  • Hauser TH, Pinto DS, Josephson ME, Zimetbaum P. Early recurrence of arrhythmia in patients taking amiodarone or class 1C agents for treatment of atrial fibrillation or atrial flutter. Am J Cardiol. 2004 May 1;93(9):1173-6. doi: 10.1016/j.amjcard.2004.01.051.
  • Freedman DS, Otvos JD, Jeyarajah EJ, Shalaurova I, Cupples LA, Parise H, D’Agostino RB, Wilson PW, Schaefer EJ. Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study. Clin Chem. 2004 Jul;50(7):1189-200. doi: 10.1373/clinchem.2004.032763. Epub 2004 Apr 23.
  • McCullough PA, Gibson CM, Dibattiste PM, Demopoulos LA, Murphy SA, Weintraub WS, Neumann FJ, Khanal S, Cannon CP; TACTICS-TIMI-18 Investigators. Timing of angiography and revascularization in acute coronary syndromes: an analysis of the TACTICS-TIMI-18 trial. J Interv Cardiol. 2004 Apr;17(2):81-6. doi: 10.1111/j.1540-8183.2004.021001.x.
  • Hodgson JM, Bottner RK, Klein LW, Walpole HT Jr, Cohen DJ, Cutlip DE, Fenninger RB, Firth BG, Greenberg D, Kalisky I, Meskan T, Powell W, Stone GW, Zito JP, Clark MA. Drug-eluting stent task force: final report and recommendations of the working committees on cost-effectiveness/economics, access to care, and medicolegal issues. Catheter Cardiovasc Interv. 2004 May;62(1):1-17. doi: 10.1002/ccd.20025.
  • Pellizzon GG, Grines CL, Cox DA, Stuckey T, Tcheng JE, Garcia E, Guagliumi G, Turco M, Lansky AJ, Griffin JJ, Cohen DJ, Aymong E, Mehran R, O’Neill WW, Stone GW. Importance of mitral regurgitation inpatients undergoing percutaneous coronary intervention for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. J Am Coll Cardiol. 2004 Apr 21;43(8):1368-74. doi: 10.1016/j.jacc.2003.11.046.
  • Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME; TAXUS-IV Investigators. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation. 2004 Apr 27;109(16):1942-7. doi: 10.1161/01.CIR.0000127110.49192.72. Epub 2004 Apr 12.
  • Jeremias A, Sylvia B, Bridges J, Kirtane AJ, Bigelow B, Pinto DS, Ho KK, Cohen DJ, Garcia LA, Cutlip DE, Carrozza JP Jr. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation. 2004 Apr 27;109(16):1930-2. doi: 10.1161/01.CIR.0000127105.99982.21. Epub 2004 Apr 12.
  • Prasad A, Stone GW, Aymong E, Zimetbaum PJ, McLaughlin M, Mehran R, Garcia E, Tcheng JE, Cox DA, Grines CL, Gersh BJ; CADILLAC trial. Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trial. Am Heart J. 2004 Apr;147(4):669-75. doi: 10.1016/j.ahj.2003.11.010.
  • Rogers C, Huynh R, Seifert PA, Chevalier B, Schofer J, Edelman ER, Toegel G, Kuchela A, Woupio A, Kuntz RE, Macon ND. Embolic protection with filtering or occlusion balloons during saphenous vein graft stenting retrieves identical volumes and sizes of particulate debris. Circulation. 2004 Apr 13;109(14):1735-40. doi: 10.1161/01.CIR.0000124724.14491.6F. Epub 2004 Apr 5.
  • Choi JW, Gibson CM, Murphy SA, Davidson CJ, Kim RJ, Ricciardi MJ. Myonecrosis following stent placement: association between impaired TIMI myocardial perfusion grade and MRI visualization of microinfarction. Catheter Cardiovasc Interv. 2004 Apr;61(4):472-6. doi: 10.1002/ccd.20024.
  • Fox CS, Parise H, Vasan RS, Levy D, O’Donnell CJ, D’Agostino RB, Plehn JF, Benjamin EJ. Mitral annular calcification is a predictor for incident atrial fibrillation. Atherosclerosis. 2004 Apr;173(2):291-4. doi: 10.1016/j.atherosclerosis.2003.12.018.
  • Gibson CM, Karha J, Murphy SA, de Lemos JA, Morrow DA, Giugliano RP, Roe MT, Harrington RA, Cannon CP, Antman EM, Califf RM, Braunwald E; TIMI Study Group. Association of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarction. J Am Coll Cardiol. 2004 Apr 7;43(7):1170-6. doi: 10.1016/j.jacc.2003.11.035.
  • Servoss SJ, Wan Y, Snapinn SM, DiBattiste PM, Zhao XQ, Theroux P, Jang IK, Januzzi JL Jr; PRISM-PLUS trial. Tirofiban therapy for patients with acute coronary syndromes and prior coronary artery bypass grafting in the PRISM-PLUS trial. Am J Cardiol. 2004 Apr 1;93(7):843-7. doi: 10.1016/j.amjcard.2003.12.021.
  • Rosito GA, D’Agostino RB, Massaro J, Lipinska I, Mittleman MA, Sutherland P, Wilson PW, Levy D, Muller JE, Tofler GH. Association between obesity and a prothrombotic state: the Framingham Offspring Study. Thromb Haemost. 2004 Apr;91(4):683-9. doi: 10.1160/th03-01-0014.
  • Sundström J, Sullivan L, Selhub J, Benjamin EJ, D’Agostino RB, Jacques PF, Rosenberg IH, Levy D, Wilson PW, Vasan RS; Framingham Heart Study. Relations of plasma homocysteine to left ventricular structure and function: the Framingham Heart Study. Eur Heart J. 2004 Mar;25(6):523-30. doi: 10.1016/j.ehj.2004.01.008.
  • Schampaert E, Cohen EA, Schlüter M, Reeves F, Traboulsi M, Title LM, Kuntz RE, Popma JJ; C-SIRIUS Investigators. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol. 2004 Mar 17;43(6):1110-5. doi: 10.1016/j.jacc.2004.01.024.
  • Murabito JM, Nam BH, D’Agostino RB Sr, Lloyd-Jones DM, O’Donnell CJ, Wilson PW. Accuracy of offspring reports of parental cardiovascular disease history: the Framingham Offspring Study. Ann Intern Med. 2004 Mar 16;140(6):434-40. doi: 10.7326/0003-4819-140-6-200403160-00010.
  • Guerra DR, Gibson CM. Door-to-Balloon Delays with PCI in Acute Myocardial Infarction. Curr Treat Options Cardiovasc Med. 2004 Feb;6(1):69-77. doi: 10.1007/s11936-004-0016-5.
  • Djoussé L, Levy D, Benjamin EJ, Blease SJ, Russ A, Larson MG, Massaro JM, D’Agostino RB, Wolf PA, Ellison RC. Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study. Am J Cardiol. 2004 Mar 15;93(6):710-3. doi: 10.1016/j.amjcard.2003.12.004.
  • Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM; Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004 Apr 8;350(15):1495-504. doi: 10.1056/NEJMoa040583. Epub 2004 Mar 8.
  • Kirtane AJ, Bui A, Murphy SA, Barron HV, Gibson CM. Association of peripheral neutrophilia with adverse angiographic outcomes in ST-elevation myocardial infarction. Am J Cardiol. 2004 Mar 1;93(5):532-6. doi: 10.1016/j.amjcard.2003.11.013.
  • Eaker ED, Sullivan LM, Kelly-Hayes M, D’Agostino RB Sr, Benjamin EJ. Anger and hostility predict the development of atrial fibrillation in men in the Framingham Offspring Study. Circulation. 2004 Mar 16;109(10):1267-71. doi: 10.1161/01.CIR.0000118535.15205.8F. Epub 2004 Mar 1.
  • Rewers M, Zaccaro D, D’Agostino R, Haffner S, Saad MF, Selby JV, Bergman R, Savage P; Insulin Resistance Atherosclerosis Study Investigators. Insulin sensitivity, insulinemia, and coronary artery disease: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 2004 Mar;27(3):781-7. doi: 10.2337/diacare.27.3.781.
  • Fox CS, Sullivan L, D’Agostino RB Sr, Wilson PW; Framingham Heart Study. The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study. Diabetes Care. 2004 Mar;27(3):704-8. doi: 10.2337/diacare.27.3.704.
  • Kovar D, Cannon CP, Bentley JH, Charlesworth A, Rogers WJ. Does initial and delayed heart rate predict mortality in patients with acute coronary syndromes?. Clin Cardiol. 2004 Feb;27(2):80-6. doi: 10.1002/clc.4960270207.
  • Januzzi JL, Isselbacher EM, Fattori R, Cooper JV, Smith DE, Fang J, Eagle KA, Mehta RH, Nienaber CA, Pape LA; International Registry of Aortic Dissection (IRAD). Characterizing the young patient with aortic dissection: results from the International Registry of Aortic Dissection (IRAD). J Am Coll Cardiol. 2004 Feb 18;43(4):665-9. doi: 10.1016/j.jacc.2003.08.054.
  • Roe MT, Green CL, Giugliano RP, Gibson CM, Baran K, Greenberg M, Palmeri ST, Crater S, Trollinger K, Hannan K, Harrington RA, Krucoff MW; INTEGRITI Investigators. Improved speed and stability of ST-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2004 Feb 18;43(4):549-56. doi: 10.1016/j.jacc.2003.09.039.
  • Fox CS, Larson MG, Corey D, Feng D, Lindpaintner K, Polak JF, Wolf PA, D’Agostino RB, Tofler GH, O’Donnell CJ. Absence of association between polymorphisms in the hemostatic factor pathway genes and carotid intimal medial thickness: the Framingham Heart Study. Stroke. 2004 Mar;35(3):e65-7. doi: 10.1161/01.STR.0000117095.96234.A6. Epub 2004 Feb 12.
  • Holmes DR Jr, Leon MB, Moses JW, Popma JJ, Cutlip D, Fitzgerald PJ, Brown C, Fischell T, Wong SC, Midei M, Snead D, Kuntz RE. Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation. 2004 Feb 10;109(5):634-40. doi: 10.1161/01.CIR.0000112572.57794.22.
  • Wiviott SD, Cannon CP, Morrow DA, Murphy SA, Gibson CM, McCabe CH, Sabatine MS, Rifai N, Giugliano RP, DiBattiste PM, Demopoulos LA, Antman EM, Braunwald E. Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy. Circulation. 2004 Feb 10;109(5):580-6. doi: 10.1161/01.CIR.0000109491.66226.26.
  • Janardhan V, Wolf PA, Kase CS, Massaro JM, D’Agostino RB, Franzblau C, Wilson PW. Anticardiolipin antibodies and risk of ischemic stroke and transient ischemic attack: the Framingham cohort and offspring study. Stroke. 2004 Mar;35(3):736-41. doi: 10.1161/01.STR.0000117575.48205.2D. Epub 2004 Feb 5.
  • Millen BE, Quatromoni PA, Nam BH, O’Horo CE, Polak JF, Wolf PA, D’Agostino RB; Framingham Nutrition Studies. Dietary patterns, smoking, and subclinical heart disease in women: opportunities for primary prevention from the Framingham Nutrition Studies. J Am Diet Assoc. 2004 Feb;104(2):208-14. doi: 10.1016/j.jada.2003.11.007.
  • Gelfand EV, Cannon CP. Antibiotics for secondary prevention of coronary artery disease: an ACES hypothesis but we need to PROVE IT. Am Heart J. 2004 Feb;147(2):202-9. doi: 10.1016/j.ahj.2003.09.011.
  • Sabatine MS, Morrow DA, Giugliano RP, Murphy SA, Demopoulos LA, DiBattiste PM, Weintraub WS, McCabe CH, Antman EM, Cannon CP, Braunwald E. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial. Circulation. 2004 Feb 24;109(7):874-80. doi: 10.1161/01.CIR.0000112604.74713.35. Epub 2004 Feb 2.
  • Fox CS, Cupples LA, Chazaro I, Polak JF, Wolf PA, D’Agostino RB, Ordovas JM, O’Donnell CJ. Genomewide linkage analysis for internal carotid artery intimal medial thickness: evidence for linkage to chromosome 12. Am J Hum Genet. 2004 Feb;74(2):253-61. doi: 10.1086/381559. Epub 2004 Jan 16.
  • Elias MF, Sullivan LM, D’Agostino RB, Elias PK, Beiser A, Au R, Seshadri S, DeCarli C, Wolf PA. Framingham stroke risk profile and lowered cognitive performance. Stroke. 2004 Feb;35(2):404-9. doi: 10.1161/01.STR.0000103141.82869.77. Epub 2004 Jan 15.
  • Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME; TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004 Jan 15;350(3):221-31. doi: 10.1056/NEJMoa032441.
  • Massaro JM, D’Agostino RB Sr, Sullivan LM, Beiser A, DeCarli C, Au R, Elias MF, Wolf PA. Managing and analysing data from a large-scale study on Framingham Offspring relating brain structure to cognitive function. Stat Med. 2004 Jan 30;23(2):351-67. doi: 10.1002/sim.1743.
  • Degertekin M, Lemos PA, Lee CH, Tanabe K, Sousa JE, Abizaid A, Regar E, Sianos G, van der Giessen WJ, de Feyter PJ, Wuelfert E, Popma JJ, Serruys PW. Intravascular ultrasound evaluation after sirolimus eluting stent implantation for de novo and in-stent restenosis lesions. Eur Heart J. 2004 Jan;25(1):32-8. doi: 10.1016/j.ehj.2003.10.012.